⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Hemab Therapeutics Holdings, Inc. Common Stock

$41.45
+0.95 (+2.35%)

Volume:

740.662K ($30.68M)

Market Capitalization:

$1.94B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Hemab Therapeutics Holdings Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$41.45
Close$41.45
Low$41.45
Low Change0.00 (0.00%)
High$41.45
High Change+0.00 (+0.00%)
Range$0.00
Volume67.751K
Dollar Volume$2.81M

Regular Trading Hours

+1.08(+2.68%)
Open$40.34
Close$41.42
Low$39.38
Low Change-0.96 (-2.38%)
High$42.85
High Change+2.51 (+6.22%)
Range$3.47
Volume672.911K
Dollar Volume$27.87M

Premarket

*No Trades in Segment

After Hours Yesterday

-0.52(-1.29%)
Open$40.42
Close$39.90
Low$39.62
Low Change-0.80 (-1.98%)
High$40.42
High Change+0.00 (+0.00%)
Range$0.80
Volume52.804K
Dollar Volume$2.11M

Regular Trading Hours Yesterday

+1.61(+4.14%)
Open$38.89
Close$40.50
Low$38.75
Low Change-0.14 (-0.36%)
High$42.23
High Change+3.34 (+8.58%)
Range$3.48
Volume1.117M
Dollar Volume$45.23M

Premarket Yesterday

*No Trades in Segment

Hemab Therapeutics Holdings Top Trades

Hemab Therapeutics Holdings's top trade so far today returned +6.22%, while the top short trade returned -3.34%.

Hemab Therapeutics Holdings Moving Averages

5 Day Moving Average (SMA5)$37.54
10 Day Moving Average (SMA10)$35.40
20 Day Moving Average (SMA20)$32.90
50 Day Moving Average (SMA50)$38.04
100 Day Moving Average (SMA100)$39.30
200 Day Moving Average (SMA200)—

Hemab Therapeutics Holdings Statistics

Average Volume (30 Days)—
P/E Ratio (Current)—
EPS (Current)—
Dividend Yield—
Free Cash Flow—
Cash Ratio—
Current Ratio—
Quick Ratio—
Debt to Equity—
Enterprise Value—
EV to EBITDA—
EV to Sales—
Price to Book—
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets—
Return on Equity—

Hemab Therapeutics Holdings Stock Splits

There have been no stock splits for Hemab Therapeutics Holdings (COAG).

Hemab Therapeutics Holdings Dividends

There have been no dividends for Hemab Therapeutics Holdings (COAG).